BioSpace News Archive

The American Cancer Society, the leading organization devoted to creating a world without cancer, will celebrate Coaches vs. Cancer Suits And Sneakers Week Jan. 20-26 during basketball games around the country.

Technavio has announced its latest market research report titled global type 1 diabetes drugs market 2019-2023.

Technavio has announced its latest market research report titled global ureteroscopy devices market 2019-2023.

Ponder & Co., a leading healthcare financial advisory firm, announced today that the company was ranked as the No. 1 financial advisor in new healthcare debt issuance, for the 2nd year in a row and the 20th time in the last 35 years (when Thomson Reuters’ began ranking Municipal Advisors in 1985*).

Pinnacle Treatment Centers, a leader in providing accessible treatment for adult men and women struggling with substance use disorder, will open Georgetown Treatment Services, Ohio’s first medication unit, on Monday

Seneca Biopharma, Inc. (Nasdaq:SNCA), today announced the agreement by several accredited investors to exercise certain warrants to purchase up to an aggregate of 5,555,554 shares of common stock having an exercise price of $2.70 issued by the company on July 30, 2019,

Genomic medicine’s groundbreaking treatments, and its future promise, will be the focus of a full-day symposium at the Hackensack Meridian Health Center for Discovery and Innovation (CDI) on Wednesday, February 19.

Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (the “Company”) announced today that its board of directors approved the record date for the Company’s 2020 Annual General Meeting of Shareholders (the “Annual Meeting”) to be held on or about March 23, 2020.

Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it reached a settlement agreement to settle two shareholder derivative actions: Watts v. Gormally, et al., No. 2:18-15992 (D.N.J.) and Chan v. Gormally, et al., No. 2:19-cv-4989 (D.N.J.).

Welltower Inc. (NYSE: WELL) today announced that it will release its fourth quarter 2019 financial results after the close of trading on the New York Stock Exchange on Wednesday, February 12, 2020.